144 related articles for article (PubMed ID: 38739668)
1. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance.
Refai NS; Louka ML; Halim HY; Montasser I
J Gene Med; 2019 Sep; 21(9):e3112. PubMed ID: 31301261
[TBL] [Abstract][Full Text] [Related]
3. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
5. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
7. Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma.
Mohyeldeen M; Ibrahim S; Shaker O; Helmy H
Clin Biochem; 2020 Oct; 84():38-44. PubMed ID: 32526227
[TBL] [Abstract][Full Text] [Related]
8. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
[TBL] [Abstract][Full Text] [Related]
10. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
[TBL] [Abstract][Full Text] [Related]
11. Identification of long non-coding RNA
Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs in HCV Infection and HCV-Related Liver Disease.
Unfried JP; Fortes P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32214045
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma.
Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
16. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
[TBL] [Abstract][Full Text] [Related]
17. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA IGF2AS in Serum may be a Biomarker for Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Qi J; Li J; Sun J; Li C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850718
[TBL] [Abstract][Full Text] [Related]
19. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
Gao S; Xu X; Wang Y; Zhang W; Wang X
Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]